Bifidobacterium animalis subsp. lactis F1-7 Probiotics Powder

1. Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis

2. Study on intestinal survival and cholesterol metabolism of probiotics

3. Evaluation of probiotics for improving and regulation metabolism relevant to type 2 diabetes in vitro

4. Study of gastrointestinal tract viability and motility via modulation of serotonin in a zebrafish model by probiotics

5. Bifidobacterium animalis F1-7 in combination with konjac glucomannan improves constipation in mice via humoral transport

6. Bifidobacterium improves oestrogen-deficiencyinduced osteoporosis in mice by modulating intestinal immunity

7. Krill Oil Combined with Bifidobacterium animalis subsp. lactis F1-7 Alleviates the Atherosclerosis of ApoE Mice

8. Mechanisms underlying the promotion of 5- hydroxytryptamine secretion in enterochromaffin cells of constipation mice by Bifidobacterium and Lactobacillus

9. Probiotics improved hyperlipidemia in mice induced by a high cholesterol diet via downregulating FXR

10. Ameliorative Effect and Mechanism of Probiotics Combined with Resveratrol on Chronic Alcoholic Liver Injury in Mice

Products customized are acceptable.

Potency:10B CFU/g, 50B CFU/g, 100B CFU/g，200B CFU/g，300B CFU/g，400B CFU/g，500B CFU/g